|
27 Jul 2020 |
Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA
|
|
27 Jul 2020 |
Aerie Pharmaceuticals Reports Positive Topline Results for AR-1105 (Dexamethasone Intravitreal Implant) Phase 2 Clinical Trial in Patients with Macular Edema Due to Retinal Vein Occlusion
|
|
27 Jul 2020 |
Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins
|
|
27 Jul 2020 |
4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of 4D-110 by Intravitreal Injection for the Treatment of Choroideremia
|
|
27 Jul 2020 |
European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis
|
|
27 Jul 2020 |
jCyte Inc. Announces Promising Phase 2b Results of jCell Therapy in Retinitis Pigmentosa
|
|
27 Jul 2020 |
ProMab Presents Promising Results in Humanized CD19 CAR-T Cells Trial
|
|
27 Jul 2020 |
TCR² Therapeutics Announces RECIST Responses with First TC-210 Dose Tested in Advanced Mesothelin-Expressing Solid Tumors
|
|
27 Jul 2020 |
MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
|
|
27 Jul 2020 |
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
|
|
27 Jul 2020 |
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19
|
|
27 Jul 2020 |
Centus Biotherapeutics Announces Positive CHMP Opinion for FKB238, Biosimilar Bevacizumab
|
|
27 Jul 2020 |
Calquence recommended for approval in the EU by CHMP for chronic lymphocytic leukaemia
|
|
27 Jul 2020 |
Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer
|
|
27 Jul 2020 |
Daiichi Sankyo and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062
|
|
25 Jul 2020 |
U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma
|
|
24 Jul 2020 |
Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics
|
|
24 Jul 2020 |
Janssen Receives CHMP Positive Opinion for Expanded Use of IMBRUVICA® (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukaemia (CLL)
|
|
24 Jul 2020 |
GSK receives positive CHMP opinion recommending approval of belantamab mafodotin for the treatment of relapsed and refractory multiple myeloma
|
|
24 Jul 2020 |
MyoKardia Announces Receipt of Breakthrough Therapy Designation from FDA for Mavacamten for the Treatment of Symptomatic, Obstructive Hypertrophic Cardiomyopathy
|
